logo BDSP

Base documentaire

  1. Treatment of bone and jount infections utilizing a third-generation cephalosporin with an outpatient drug delivery device.

    Article - En anglais

    The purpose of this study was to determine the efficacy, safety, and cost effectiveness of a third-generation cephalosporin, cefotaxime, administered via an ambulatory delivery system (ADS) in the treatment of bone and joint infections (BJI).

    A total of 27 BJI patients enrolled as a subgroup of a multicenter, prospective, open-label trial were administered 1-2 g of cefotaxime every 8 hours using ADS.

    Of these patients, 18 were evaluable, with the causative organisms identified and susceptible to cefotaxime.

    Mots-clés Pascal : Bactériose, Infection, Os, Articulation, Céfotaxime, Antibiotique, Céphalosporine dérivé, Chimiothérapie, Ambulatoire, Coût, Traitement, Homme, Système ostéoarticulaire pathologie, Ostéopathie, Epidémiologie

    Mots-clés Pascal anglais : Bacteriosis, Infection, Bone, Joint, Antibiotic, Cephalosporin derivatives, Chemotherapy, Ambulatory, Costs, Treatment, Human, Diseases of the osteoarticular system, Bone disease, Epidemiology

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 94-0668343

    Code Inist : 002B02S02. Création : 09/06/1995.